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RESUMEN
Se obtienen las 4,6-diaril-1H-pirazolo[3,4-b]piridin-3-ami-
nas 4a-c en estado muy puro y se usan como buenos
productos de partida para el presente estudio. El com-
puesto 4a se diazotiza para dar la correspondiente sal
de diazonio 11 y, además, se hace reaccionar con 2-bro-
mo-1-feniletanona para dar el correspondiente derivado
de pirazolo[3,4-b]piridin-2-il)-1-feniletanona 7 que se usa
para preparar los derivados de hidrazona 8 y de forma-
mida 10 mediante reacción con hidrato de hidrazina y
ácido fórmico, respectivamente. El compuesto 11 se uti-
liza para preparar derivados de piridopirazolotriazina vía
acoplamiento con diversos compuestos que contienen
–CH2- activos. Se determina la estructura química de los
nuevos compuestos heterocíclicos sintetizados a partir
de los datos de IR, 1H-RMN, espectros de masas y aná-
lisis elementales.
Palabras clave: Cianoetantioamida. 2-metiltionicotinoni-
trilo. Pirazolopiridina. Hidrazona. Formamida. Pirazolo-
piridinilhidrazono. Piridopirazolotriazina.
SUMMARY
4,6-Diaryl-1H-pyrazolo[3,4-b]pyridin-3-amines 4a-c were
obtained in very pure state and used as the good star-
ting materials for the present study. Compound 4a dia-
zotized to give the corresponding diazonium salt 11 and
also, reacted with 2-bromo-1-phenylethanone to give the
corresponding pyrazolo[3,4-b]pyridin-2-yl)-1-phenylet-
hanone derivative 7 which in turn, used for the prepara-
tion of the hydrazone and formamide  derivatives 8 and
10 respectively through its reaction with hydrazine hydra-
te and formic acid respectively. Compound 11 was used
for the preparation of pyridopyrazolotriazine derivatives
via its coupling with several active –CH2- containing com-
pounds. Considering the data from IR, 1H NMR, the mass
spectra and elemental analyses the chemical structures
of the newly synthesized heterocyclic compounds were
elucidated. 
Key words: Cyanoethanethioamide. 2-methylthionicoti-
nonitrile. Pyrazolopyridine. Hydrazone. Formamide.
Pyrazolopyridinylhydrazono and Pyridopyrazolotriazine.  
RESUM
S’obtenen les 4,6-diaril-1H-pirazolo[3,4-b]piridin-3-ami-
nes 4a-c en estat molt pur i s’empren com a bons pro-
ductes de partida per al present estudi. El compost 4a
es diazotitza per donar la corresponent sal de diazoni 11
i a més, es fa reaccionar amb 2-bromo-1-feniletanona
per donar el corresponent derivat de pirazolo[3,4-b]piri-
din-2-il)-1-feniletanona 7, que s’empra per preparar els
derivats d’hidrazona 8 i de formamida 10 mitjançant reac-
ció amb hidrat d’hidrazina i àcid fòrmic, respectivament.
El compost 11 s’utilitza per preparar derivats de pirido-
pirazolotriazina via acoblament amb diversos compos-
tos que contenen –CH2- actius. Es determina l’estructu-
ra química dels nous compostos heterocíclics sintetitzats
a partir de les dades de IR, 1H-RMN, espectres de mas-
ses i anàlisis elementals.
Mots clau: Cianoetantioamida. 2-metiltionicotinonitrilo.
Pirazolopiridina. Hidrazona. Formamida. Pirazolopiridi-
nilhidrazono. Piridopirazolotriazina.
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INTRODUCTION
In previous papers(1-22) the synthesis of pyrazolopyridi-
ne and pyridopyrazolotriazine derivatives were des-
cribed. As a continuation of our research on the synt-
hesis of these ring systems and owing to the reported
biological activities of pyrazolopyridine(23-25) and as well
as that of triazines,(26-30) we were interested to synthe-
size several derivatives of these ring systems that are
required for several chemical transformation as well as
for our medicinal chemistry program.
RESULTS AND DISCUSSION
The synthetic potentiality of 1a-c was used to build up
new ring containing active functional groups, this goal
achieved through their reaction with hydrazine hydrate.
Thus, it has been found that 1a reacted with methyl iodi-
de in methanolic sodium methoxide to afford the corres-
ponding 4-(4-bromophenyl)-2-(methylthio)-6-phenylni-
cotinonitrile 2a which in turn, reacted with hydrazine
hydrate in ethanol to give the sulfur free product that
formulated as 4-(4-bromophenyl)-6-phenyl-1H-pyrazo-
lo[3,4-b]pyridin-3-amine 4a through the non-isolable
product 3a. Chemical structure of 4a was elucidated
based on the spectroscopic and elemental analyses (cf.
Exp. Part). A further elucidation of structure 4a arose
from its preparation authentically, thus 1a reacted with
hydrazine hydrate to afford directly 4a through the hydro-
gen sulfide molecule removal. It is remarkable to report
here that the products of the two pathways were iden-
tical in all physical and chemical properties (cf. Exp.
Part). Similarly, 1H-pyrazolo[3,4-b]pyridin-3-amine deri-
vatives 4b,c were synthesized by the reaction of either
1b,c or 2b,c with hydrazine hydrate and their structures
were elucidated by considering the data of elemental
and spectroscopic analyses (cf. Exp. Part and Chart 1).
The chemical reactivity and synthetic potentiality of
4a was investigated through its reaction with 2-bro-
mo-1-phenylethanone (6) in stirred DMF/KOH on cold
to give the corresponding 2-(3-amino-4-[4-bromop-
henyl]-6-phenyl-2H-pyrazolo[3,4-b]pyridin-2-yl)-1-
phenylethan-one (7). The reaction seemed to be pro-
ceeded through the dehydrobromination between the
tautomer 5 and 6.
The IR, 1H NMR, and elemental analyses of this reac-
tion product found to be in a good agreement with the
assigned structure (cf. Exp. Part and Chart 2).
Furthermore, the structure of compound 7 was confir-
med chemically through its reaction with both hydra-
zine hydrate and formic acid. Thus, it has been found
that compound 7 reacted with hydrazine hydrate under
reflux 3-5 hours to afford the reaction product which
assumed to be formed via the condensation of 7 with
hydrazine hydrate to give the final isolable hydrazone
derivative 8 which confirm the presence and chemical
reactivity of CO group. The IR (cm–1) of this reaction
product showed no bands of C=O and instead the newly
formed = N-NH2 group was detected. 
On the other hand, the 1H NMR spectrum of this reac-
tion product revealed the signals of NH2 at pyrazole
ring and =N-NH2 protons. Moreover, its mass spectrum
gave m/z = 497 (M+, 14.9%) which corresponding to
the molecular weight of the molecular formula C26H21BrN6
of the assigned structure. Several peaks such as 364
[M-CH2-C(Ph) = N-NH2, 100%], 335 (364-N2, 20%) and
270 (335-C3H5N2, 13.1%) were detected and their detec-Chart 1
Chart 2
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tion elucidates structure 8 (cf. Exp. Part). Considering the
above-mentioned data in addition to that of elemental analy-
ses it is concluded that this reaction product formulated
as 2-(3-amino-4-(4-bromophenyl)-6-phenyl-2H-pyrazo-
lo[3,4-b]pyridin-2-yl)-1-phenyl-ethanone hydrazone 8 not
triazine derivative 9 (cf. Chart 2 and Exp. Part).
The position and chemical reactivity of NH2 in 7 could be
established through its reaction with formic acid. It has
been found unexpectedly that the IR (cm-1) of this reaction
product showed the bands of C=O, NH function and the
1H NMR (δppm) showed the signals of aldehydic, NH and
-CH2COPh protons. Moreover, the mass spectrum of this
reaction product gave m/z = 511 (M+, 11.1%) which corres-
ponding to the molecular weight of the molecular formula
C27H19BrN4O2 of the assigned structure, in addition to the
peak at m/z = 405 (M-COPh, H, 71.5%) and m/z = 77 (for
the fragment Ph, 100%). Considering the above mentio-
ned data we can conclude that N-[4-(4-bromophenyl)-2-
(2-oxo-2-phenylethyl)-6-phenyl-2H-pyrazolo[3,4-b]pyridin-
3-yl]formamide 10 represents the reaction product (cf. Chart
2 and Exp. Part).
The chemical reactivity of 4a was further investigated via its
reaction with nitrous acid to give the corresponding 4-(4-
bromophenyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridine-3-dia-
zonium chloride (11). Compound 11 used as a good synt-
hon for the preparation of several pyrido[2',3':3,4]pyrazo-
lo[5,1-c]triazine derivatives 15a-f. Thus, it has been found
that compound 11 coupled with each of malononitrile, ethyl
cyanoacetate and 2-cyanoethanethioamide (12a-c) in sti-
rred ethanol-sodium acetate on cold. The IR (cm-1) of the
reaction product in case of 12a showed the bands of CN,
NH2 groups. The reaction product in case of 12b showed
the bands of NH2, CO (ester) in its IR spectrum and its 1H
NMR spectrum revealed the signals of COOCH2CH3 protons.
On the other hand, the reaction product in case of 12c sho-
wed the bands of NH2, C=S in IR spectrum. Moreover, the
mass spectra of these reaction products gave m/z = 442,
489 and 476 and these corresponding to the molecular
weights of the molecular formulas C21H12BrN7, C23H17BrN6O2
and C21H14BrN7S respectively in addition to several fragments
confirm the structures 15a-c (cf. Chart 3 and Exp. Part).
Considering the above-mentioned data (cf. Exp. Part) we
concluded that the reaction seemed to be proceeded via
dehydrochlorination between each of 12a-c and 11 to afford
the corresponding non-isolable derivatives 13a-c, 14a-c res-
pectively which spontaneously cyclized to afford the corres-
ponding triazines 15a-c. 
Similarly, synthon 11 reacted with each
of diethylmalonate, acetylacetone and
ethyl acetoacetate 12d-f under the same
above-mentioned experimental conditions
to afford the corresponding pyrido-
[2’,3’:3,4]pyrazolo[5,1-c][1,2,4]triazines 15d-
f via the non-isolable intermediates 13d-f
respectively. By considering the data of IR,
1H NMR and elemental analyses (cf. Exp.
Part) the chemical structures of each of
15d-f were elucidated. Moreover, the mass
spectra of 15d-f gave m/z = 490, 458 and
488 which corresponding to the molecular
weights of the molecular formulas
C23H16BrN5O3, C23H16BrN5O and C24H18BrN5O2
of the assigned structures. The presence
of broad band in IR spectrum of 15d con-
firm the presence of more stable enol-form
and this confirmed further by the detection
of peak at 489 (M+–1) at mass spectrum (cf.
Chart 4 and Fig. 1). The presence of a peak
at m/z = 488 in mass spectrum for the reac-
tion product of 11 with 12f confirm the
structure 15f and reject that of 15g and this
also, further confirmed by the presence of
signal at δ(ppm) 1.4 (t, 3H, COOCH2CH3) and
4.5 (q, 2H, COOCH2CH3) and absence of
m/z = 460 for the molecular formula
C22H14BrN5O2 of the structure 15g (cf. Charts
4, Fig. 2, and Exp. Part). An authentic sam-
ples of pyrido[2’,3’:3,4]pyrazolo[5,1-c]-
[1,2,4]triazines 15a-f obtained through anot-
her pathway via the reaction of each of
12a-f with 11 in ethanol containing the
catalytic amounts of triethylamine under
reflux 3-5hrs. It is important to report here
that compounds obtained through the two
pathways are identical in all physical and
chemical properties.             
Chart 3
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Figure 1
Chart 4
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EXPERIMENTAL
All melting points were uncorrected. I.R. (KBr discs) spec-
tra were recorded on a Shimadzu FTIR-8201PC
Spectrophotometer. 1H-NMR spectra were recorded on a
Varian Mercury 300 MHz., and a Varian Gemini 200 MHz.
spectrometers using TMS as an internal standard and CDCl3,
DMSO-d6, and (CD3)2CO as solvents. Chemical shifts were
expressed as δ (ppm) units. Mass spectra were recorded
on Shimadzu GCMS-QP1000EX using an inlet type at 70
eV. The Microanalytical Center of Cairo University perfor-
med the microanalyses.
Synthesis of 2a-c: (General Procedure): Mix each of 2-
thioxopyridine derivatives 1a-c (0.1 mole) and iodometha-
ne (0.15 mole) in methanolic sodium methoxide (0.23 g of
sodium with about 30-50 mL methanol). Stir on cold for 1-
1.5 hours then pour onto ice-cold water and acidified with
concentrated HCl. Collect the formed solids by filtration
and wash with water then crystallize from the proper sol-
vent to afford 2a-c respectively.
4-(4-bromophenyl)-2-(methylthio)-6-phenylnicotinonitri-
le 2a: crystallized from acetic acid as yellowish-white crys-
tals (64%); m.p 260 ºC; IR (ν cm–1): 2218 (CN) and 1605
(C=C); Anal. for C19H13BrN2S (381.28): Calcd./Found (%):
C,59.85/60.10, H,3.44/3.50, Br,20.96/21.0, N,7.35/7.30,
S,8.41/8.50.
4-[4-(dimethylamino)phenyl]-2-(methylthio)-6-phenylni-
cotinonitrile 2b: crystallized from ethanol as pale yellow
crystals (64%); m.p 222 ºC; IR (ν cm–1): 2218 (CN) and 1605
(C=C); Anal. for C21H19N3S (345.46): Calcd./Found (%):
C,73.01/73.10, H,5.54/5.50, N,12.16/12.20, S,9.28/9.30.
4-[4-(dimethylamino)phenyl]-6-(4-methylphenyl)-2-
(methylthio)-nicotinonitrile 2c: crystallized from ethanol
as orange crystals (66%); m.p 220 ºC; IR (ν cm–1): 2222 (CN)
and 1602 (C=C); Anal. for C22H21N3S (359.48): Calcd./Found
(%): C,73.50/73.50, H,5.89/5.90, N,11.69/11.50, S,8.92/9.0.
Synthesis of 4a-c: A mixture of 1a-c or 2a-c (0.01 mole of
each) and hydrazine hydrate (20-25 mL) and pyridine (20
mL) was heated under reflux for 20 hours till the odour of
H2S or CH3SH ceased. The products so formed after coo-
ling were filtered off, washed with cold ethanol, and crys-
tallized from the proper solvent to give 4a-c respectively.
4-(4-Bromophenyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridin-
3-amine 4a: crystallized from ethanol as yellow crystals
(58 %); mp.232-4 ºC; IR (cm–1): 3466, 3302, 3194 (NH2, NH),
2858 (sat. CH) and 1642 (C=N); Anal. for C18H13BrN4 (365.22):
Calcd./Found (%): C,59.19/59.30, H,3.59/3.60,
Br,21.88/21.70,   N,15.34/15.40.
4-[4-(Dimethylamino)phenyl]-6-phenyl-1H-pyrazolo[3,4-
b]pyridin-3-amine 4b: crystallized from ethanol as yellow
crystals (65 %); mp.256-8 ºC; IR (cm–1): 3446, 3287, 3185
(NH2, NH) and 1638 (C=N); Anal. for C20H19N5 (329.39):
Calcd./Found (%): C,72.93/73.0,   H,5.81/5.9, N,21.26/21.30.  
4-[4-(Dimethylamino)phenyl]-6-(4-methylphenyl)-1H-pyra-
zolo[3,4-b]-pyridin-3-amine 4c: crystallized from ethanol
as yellow crystals (65%); mp.256-8 ºC; IR (cm–1): 3462, 3309,
3194 (NH2, NH) and 1641 (C=N); Anal. for C21H21N5 (343.42):
Calcd./Found (%): C,73.44/73.3, H,6.16/6.20,   N,20.39/20.40.  
Synthesis of 7: A solution of 4a and potassium hydroxide
(0.01 mole of each) in DMF (30 mL) stirred with 2-bromo-1-
phenylethanone (6) (0.01 mole) for 30 minutes on cold. Pour
onto ice-cold water, the solid so formed was filtered off,
washed with water, and crystallized from ethanol to give 7.
2-(3-Amino-4-(4-bromophenyl)-6-phenyl-2H-pyrazolo[3,4-
b]pyridin-2-yl)-1-phenylethanone 7: as yellow crystals (60
%); mp.194-6 ºC; IR (cm–1): 3418, 3294, 3189 (NH2), 3059 (CH-
aromatic) and 1692 (C=O); 1H-NMR (δ): 2.60 (s, 2H, -CH2-),
5.67 (s, br., 2H, NH2) and 7.08-7.89 (m, 15H, aromatic and pyri-
dine-CH protons); MS: 483 (M+, 11.1%) which corresponding
to the molecular weight of the molecular formula C26H19BrN4O
of the assigned structure, 484 (M+1, 10.6 %), 485 (M+2, 8.5
%), 482 (M+–H, 9.8%), 380 (M+–PhCN, 72.5%), 379 (482-PhCN,
96.6%), 377 (482-PhCO, 100%), 363 (M+–PhCOCH2, 1.6%),
105 (PhCO, 41.7%), 103 (PhCN, 1.5%) and 77 (Ph, 61.8%);
Anal. for C26H19BrN4O (483.35): Calcd./Found (%): C,64.61/65.0,
H,3.96/4.0,   Br,16.53/16.40, N,11.59/11.60. 
Synthesis of 8: A mixture of 7 (0.01 mole), hydrazine hydra-
te (20-25 mL) and ethanol (25 mL) was heated under reflux
for 5-7 hours. The product so formed after cooling was fil-
tered off, washed with cold ethanol, and crystallized from
diluted ethanol to give 8.
2-(3-amino-4-(4-bromophenyl)-6-phenyl-2H-pyrazolo[3,4-
b]pyridin-2-yl)-1-phenylethanone hydrazone 8: as yellow
crystals (57%); mp.114-6 ºC; IR (cm–1), 3311 (NH2), 3055
(CH-aromatic) 2966(aliphatic CH) and 1578 (C=N); 1H-NMR
Figure 2
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(δ): 1.55 (s, 2H, -CH2-), 5.41 (s, br., 2H, NH2 at pyrazole), 6.75
(s, br., 2H, NH2, N=NH2) and 7.13-8.02 (m, 15H, aromatic
and pyridine-CH protons); MS: 497 (M+, 14.9%) which
corresponding to the molecular weight of the molecular
formula C26H21BrN6 of the assigned structure, 496 (M
+-H,
23.4%), 480 (M+–NH2, 46.9%), 377 (M
+–PhC = N–NH2, 73.1%),
364 (M+–133, –CH2-C(Ph)-N = NH2, 100%), 335 (364-N2, H,
20%); Anal. for C26H21BrN6 (497.38): Calcd./Found (%):
C,62.78/62.80, H,4.26/4.30,   Br,16.06/16.10, N,16.90/17.10.  
Synthesis of 10: A mixture of 7 (0.01 mole) and formic acid
(20-25 mL) was heated under reflux for 5-7 hours. The pro-
duct so formed after cooling was filtered off, washed with
cold ethanol, and crystallized from dioxane to give 10.
N-[4-(4-bromophenyl)-2-(2-oxo-2-phenylethyl)-6-phenyl-
2H-pyrazolo-[3,4-b]pyridin-3-yl]formamide 10: as pale
yellow crystals (67%); mp. 262-4 ºC; IR (cm–1): 3178 (NH),
3058 (CH-aromatic), 2965 (aliphatic CH), 1699 (CO) and
1580 (C=N); 1H-NMR (δ): 2.11 (s, 2H, -CH2-COPh), 6.26 (s,
br., 1H, NH), 7.51-8.23 (m, 15H, aromatic and pyridine-CH
protons) and 10.26 (s, 1H, -CHO); MS: 511 (M+, 11.1%) which
corresponding to the molecular weight of the molecular
formula C27H19BrN4O2 of the assigned structure, 512 (M+1,
15 %), 513 (M+2, 11.3 %), 510 (M+–H, 13.7%), 405
(M+–COPh, 71.5%), 392 (M+-CH2-COPh, 1.4%), 377
(M+–NCH2COPh, 54.4 %), 363 (377–N, 3.5 %), 334 (363-
CHO, 1.6%), 77 (Ph, 100%); Anal. for C27H19BrN4O2
(511.36): Calcd./Found (%): C,63.42/63.50, H,3.75/3.70,
Br,15.63/15.70, N,10.96/11.10.
Synthesis of 11: Mix 4a (0.01 mole), HCl (1.5 mL) and ace-
tic acid (5 mL). Dissolve the formed salt in about 10 ml cold
water. Add a mixture sodium nitrite (0.01 mole) and cold
water drop wise. Stir for 30 min. then filter the formed solid,
wash with water and crystallize the formed solid from etha-
nol to give 11.
4-(4-bromophenyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridine-
3-diazonium chloride (11): as yellow crystals (62%);
mp.180-2 ºC; IR (cm–1): 3454 (NH), 3048 (CH-aromatic) and
2232 (N≡N); Anal. for C18H11BrClN5 (412.67): Calcd./Found
(%): C,52.39/52.40, H,2.69/2.70, Br,19.36/19.30,
Cl,8.59/8.60,   N,16.97/17.0.
Synthesis of 15a-f: (General Procedure):
Method A: A solution of 12a-f (0.01 mole) in ethanol (50
mL) containing fused sodium acetate (2g) was stirred for
30 min. in ice-cold mixture. Add a mixture of each of 11 in
ethanol (50 mL) drop wise, stir for 1hr after complete addi-
tion.  The solids so obtained were filtered off, washed with
water and crystallized from the proper solvent to give 15a-
f respectively.
Method B: A solution of 11 (0.01 mole) in ethanol (50 mL)
and each of 12a-f (0.01 mole) in the presence of triethyla-
mine (0.5 mL) was heated under reflux for 3 hrs. The solids
so obtained were filtered off and crystallized from the pro-
per solvent to give 15a-f respectively.
4-Amino-10-(4-bromophenyl)-8-phenylpyrido[2’,3’:3,4]pyra-
zolo[5,1-c][1,2,4]triazine-3-carbonitrile 15a: crystallize from
ethanol-DMF mixture as orange crystals (60%); mp. >320
ºC; IR (cm–1): 3413, 3323, 3159 (NH2) and 2227 (CN); MS:
442 (M+, 56.7 %) which corresponding to the molecular
weight of the molecular formula C21H12BrN7 of the assigned
structure, 443 (M+1, 100 %), 444 (M+2, 25.22 %), 441 (M+–H,
100 %), 425 (M+–NH2, 32.38 %), 268 (M
+–C6H2N7, 25.29 %);
Anal. for C21H12BrN7 (442.27): Calcd./Found (%): C,57.03/57.0,
H,2.73/2.80, Br,18.07/18.10, N,22.17/22.20.
Ethyl 4-amino-10-(4-bromophenyl)-8-phenylpyrido [2’,3’:3,4]
pyrazolo- [5,1-c][1,2,4]triazine-3-carboxylate 15b: crysta-
llize from ethanol-DMF mixture as orange crystals (58%);
mp. >300 ºC; IR (cm–1), 3398, 3220, 3124 (NH2), 2927 (CH-
aliphatic) and 1693 (C=O); 1H-NMR (δ): 1.25 (t, 3H,
CH3CH2COO), 4.18 (q, 2H, CH3CH2COO), 7.50-8.41 (m, 10H,
aromatic and pyridine-CH protons) and 8.78 (s, br. 2H, NH2);
MS: 489 (M+, 16.36%) which corresponding to the molecu-
lar weight of the molecular formula C23H17BrN6O2 of the assig-
ned structure, 490 (M+1, 54.75%), 491 (M+2, 12.97%), 488
(M+–H, 53.34%), 459 (488-C2H5, 14.86%), 416 (M
+–COOC2H5,
51.89%), 388 (416–N2, 19.22%), 364 (M
+–COOC2H5-N2-C2,
100%), 334 (364-NNH2, 8.88%), 103 (PhCN, 7.30%); Anal. for
C23H17BrN6O2 (489.32): Calcd./ Found (%): C,56.45/56.50,
H,3.50/3.60, Br,16.33/16.20, N,17.17/17.20.
3-[Aminosulfanylidyne)methyl]-10-(4-bromophenyl)-8-
phenylpyrido-[2’,3’:3,4]pyrazolo[5,1-c][1,2,4]triazin-4-ami-
ne 15c: crystallize from ethanol-DMF mixture as yellow
crystals (60 %); mp. >320 ºC; IR (cm–1), 3457, 3318, 3162
(two NH2) and 2925 (CH-aliphatic); MS: 477 (M+1, 16 %),
475 (M+–H, 16.62%), 459 (475-NH2, 37.08%), 443 (475-S,
100%), 416 (M+–CSNH2, 27.54%), 388 (416-N2, 21.54%), 103
(PhCN, 21.69%); Anal. for C21H14BrN7S (476.35): Calcd./Found
(%): C,52.95/53.0, H,2.96/3.10, Br,16.77/16.80,
N,20.58/20.60, S,6.73/6.70.
Ethyl 10-(4-bromophenyl)-4-oxo-8-phenyl-3,4-dihy-
dropyrido[2’,3’:3,4]–pyrazolo[5,1-c][1,2,4]triazine-3-car-
boxylate 15d: crystallize from ethanol-DMF mixture as
orange crystals (56 %); mp. >300 ºC; IR (cm–1): 3400, 3200
(H-bonded OH), 2981 (CH-aliphatic) and 1714 (CO ester);
MS: 489 (M+–H, 0.59 %), 460 (489-CH3CH2, 1.23 %), 458
(M+-OH, CH3, 1.58 %), 428 (458-OCH2, 1.86 %), 400 (428-
N2, 1.62 %), 388 (400-C, 1.58 %), 285 (388-PhCN, 5.38%),
73 (COOEt, 81.16%), 68 (–N=N–C–CO–, 24.46%), 103 (PhCN,
5.46 %), 73 (COOC2H5, 81.16%); Anal. for Molecular Formula
C23H16BrN5O3 (490.30): Calcd./Found (%): C,56.34/56.50,
H,3.29/3.30, Br,16.30/16.40, N,14.28/14.30.
1-[10-(4-Bromophenyl)-4-methyl-8-phenylpyrido
[2’,3’:3,4]pyrazolo-[5,1-c][1,2,4]triazin-3-yl]ethanone 15e:
crystallize from ethanol-DMF mixture as orange crystals
(52%); mp. 320 ºC; IR (cm–1): 3073 (CH aromatic), 2923 (CH-
aliphatic) and 1697 (CO acetyl); 1H-NMR (δ): 1.27 (s, 3H,
CH3), 2.11 (s, 3H, COCH3), 7.63-8.48 (m, 10H, aromatic and
pyridine-CH protons); MS: 458 (M+, 30.56%) which corres-
ponding to the molecular weight of the molecular formula
C23H16BrN5O of the assigned structure, 459 (M+1, 100 %),
460 (M+2, 26.49 %), 415 (M+–COCH3, 8,71%), 416 (459-
COCH3, 29.76%), 387 (415–N2, 8.21 %), 388 (416–N2, 9.72 %);
103 (PhCN, 3.02%); Anal. for Molecular Formula C23H16BrN5O
(458.31): Calcd./Found (%): C,60.27/60.30, H,3.52/3.60,
Br,17.43/17.40, N,15.28/15.30.
Ethyl 10-(4-bromophenyl)-4-methyl-8-phenylpyrido[2’,3’:3,4]
pyrazolo-[5,1-c][1,2,4]triazine-3-carboxylate 15f: crysta-
llize from ethanol-DMF mixture as orange crystals (58 %);
mp. 258-60 ºC; IR (cm–1): 3049 (CH aromatic), 2923 (CH-
aliphatic) and 1719 (CO ester); 1H-NMR (δ): 1.49 (s, 3H, CH3),
1.57 (t, 3H, CH3CH2COO), 4.63 (q, 2H, COOCH2CH3) and
7.26-8.37 (m, 10H, aromatic and pyridine-CH protons); MS:
488 (M+, 15.98%) which corresponding to the molecular
weight of the molecular formula C24H18BrN5O2 of the assig-
ned structure, 489 (M+1, 54.94%), 460 (M+1–C2H5, 12.79%),
459 (M+–C2H5, 38.04%), 415 (M
+–COOC2H5, 98.03%), 416
(M+1-COOC2H5, 63.17%), 387 (415-N2, 12.60%), 388 (416-
N2, 50.95%), 361 (388-CCH3, 7.37%), 348 [M
+–N2C(COOC2H5)
= C(CH3), 10.82%]; Anal. for Molecular Formula C24H18BrN5O2
(488.33): Calcd./Found (%): C,59.03/59.10, H,3.72/3.80,
Br,16.36/16.40, N,14.34/14.20.
TRIPA AFIN 534  13/6/08  12:54  Página 168
AFINIDAD LXV, 534, Marzo-Abril 2008 169
BIBLIOGRAPHY
(1). F.A. Attaby: Arch. Pharmcol. Res., 13, 342 (1990).
(2). F.A. Attaby, L. I. Ibrahim, S. M. Eldin and A. K. K El-louh:
Phosphorous, Sulfur and Silicon, 73, 127 (1992).
(3). F.A. Attaby, S. M. Eldin and M. Abdel Razik: Phosphorous,
Sulfur and Silicon, 106, 21 (1994). 
(4). F.A. Attaby and A.M. Abdel-Fattah: Phosphorous, Sulfur
and Silicon, 119, 257 (1996).
(5). F.A. Attaby: Phosphorous, Sulfur and Silicon, 126, 27
(1997).
(6). F.A. Attaby: Phosphorous, Sulfur and Silicon, 139, 1
(1998).
(7). F.A. Attaby, S.M. Edin and M. A. A. Elneairy: Heteroatom
Chemistry, 9, 571 (1998).
(8). F.A. Attaby, S.M. Edin and M.A.A. Elneairy; J. Chem. Res.
(M), 10, 2754, (S) 10 (1998).
(9). F.A. Attaby, M.A.A. Elneairy and M.S. Elsayed:
Phosphorous, Sulfur and Silicon, 149, 230 (1999).
(10).  F.A. Attaby and A.M. Abdel-Fattah: Phosphorous, Sulfur
and Silicon, 155, 253 (1999).
(11). M.A.A. Elneairy, Sanaa M. Eldin, Fawzy A. Attaby and
A.K.K. El-Louh: Phosphorous, Sulfur and Silicon, 167, 289
(2000).
(12). M.A.A. Elneairy, F.A. Attaby and M.S. Elsayed:
Phosphorus, Sulfur and Silicon, 167, 161 (2000).
(13). F.A. Attaby, M.A.A. Elneairy, S.M. Eldin and A.K.K. El-
Louh: J. C. C. S. (China); 48(5), 893 (2001).
(14). F.A. Attaby, H.M. Mostafa, A.H.H. Elghandour and Y.M.
Ibrahem: Phosphorus, Sulfur and Silicon; 177, 2753 (2002).
(15). F.A. Attaby, A.H.H. Elghandour, H.M. Mustafa and Y.M.
Ibrahem: J. C. C. S. (China); 49(4), 561 (2002).
(16). F.A. Attaby, S.M. Eldin, M.A.A. Elneairy and A.K.K. Elouh:
Phosphorus, Sulfur and Silicon; 179, 2205 (2004).
(17). F.A. Attaby, A.H.H. Elghandour, Ali M.A. and Y.M.
Ibrahem: Phosphorus, Sulfur and Silicon; 181, 1 (2006).
(18). F.A. Attaby, Ali M.A., A.H.H. Elghandour and Y.M.
Ibrahem: Phosphorus, Sulfur and Silicon; 181, 1087 (2006).
(19). Fawzy A. Attaby, A.H.H. Elghandour, M.A. Ali and Yasser
M. Ibrahem: Afinidad; 63, 525 (2006). 
(20). Fawzy A. Attaby, A.H. Elghandour, M.A. Ali and Yasser
M. Ibrahem: Phosphorus, Sulfur and Silicon; 182, 133 (2007).
(21). Fawzy A. Attaby, A.H.H. Elghandour, M.A. Ali and Yasser
M. Ibrahem: Phosphorus, Sulfur and Silicon; 182, 695 (2007).
(22). Fawzy A. Attaby, Mostafa M. Ramla and Eman M. Gouda:
Phosphorus, Sulfur and Silicon; 182, 517 (2007).
(23_. B.R. Tolf, R. Dahlbom, H. Theroell, and A. Akeson:  Acta
Chem. Scand., Ser. B.; 36, 101 (1982).
(24). M. Komuro, R. Ishida and H. Uchida: Arzneium-Forsch,
42, 48 (1992); C. A., 116, 98851q (1992).
(25). F.E. Goda, A.A.M. Abdel-Aziz and O.A. Attef: Bioorg.
Med. Chem. 12, 1845 (2004). 
(26). F.C. Brown and C.K. Bradsher: Nature; 168, 171 (1951).
(27). D.R. Rao, S.P. Raychaudhuri and V.S. Verma: Inter-
national Journal of Tropical Plant Diseases; 12, 177 (1994). 
(28). F. Szurdki, L. Jaerger, A. Harris, H. Kido, I. Wengatz and
M.H. Goodrow: Journal of Environmental Science and
Health part B; 31, 451  (1996).
(29). F.F. Benzie and J.J. Strain: Anal. Biochem.; 15, 239
(1996).
(30). P.G. Baraldi, B. Cacciari, A. Dalpiaz and S. Dionisotti:
Arzneium-Forsch; 46, 365 (1996).
TRIPA AFIN 534  13/6/08  12:54  Página 169
